BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
30992884
- Number of visits today
- 9108
- Number of downloads
-
13527891
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Christ L, Seitz L, Scholz G, Sarbu A, Amsler J, Bütikofer L, Tappeiner C, Kollert F, Reichenbach S, Villiger PM. Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study. The Lancet Rheumatology 2021;3:e619-26. [DOI: 10.1016/s2665-9913(21)00152-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
2 |
Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Misra DP, Rathore U, Patro P, Agarwal V, Sharma A. Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis. Rheumatol Int 2021;41:1729-42. [PMID: 34302232 DOI: 10.1007/s00296-021-04958-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345